Vladimir Bobkov
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Constitutive activity of an atypical chemokine receptor revealed by inverse agonistic nanobodies.
Journal: bioRxiv : the preprint server for biology
Published: November 22, 2024
Constitutive activity of an atypical chemokine receptor revealed by inverse agonistic nanobodies.
Journal: Nature communications
Published: November 04, 2024
Multivalent CXCR4-targeting nanobody formats differently affect affinity, receptor clustering, and antagonism.
Journal: Biochemical pharmacology
Published: April 10, 2024
TR-FRET between engineered nanobodies reveals the existence of endogenous CXCR4 oligomers.
Journal: Communications biology
Published: November 20, 2023
Differential effects of FcRn antagonists on the subcellular trafficking of FcRn and albumin.
Journal: JCI insight
Published: October 04, 2023
Conformational selection guides β-arrestin recruitment at a biased G protein-coupled receptor.
Journal: Science (New York, N.Y.)
Published: July 20, 2022
Advanced fluorescence microscopy reveals disruption of dynamic CXCR4 dimerization by subpocket-specific inverse agonists.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: November 05, 2020
Natural Killer Cell Hypo-responsiveness in Chronic Lymphocytic Leukemia can be Circumvented In Vitro by Adequate Activating Signaling.
Journal: HemaSphere
Published: July 11, 2019
Antibodies Targeting Chemokine Receptors CXCR4 and ACKR3.
Journal: Molecular pharmacology
Published: April 22, 2019
Nanobodies: New avenues for imaging, stabilizing and modulating GPCRs.
Journal: Molecular and cellular endocrinology
Published: October 15, 2018
Last Updated: 09/26/2026